Erciyes University Faculty of Health Sciences
About Erciyes University Faculty of Health Sciences
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Erciyes University Faculty of Health Sciences
During the past decade, Erciyes University Faculty of Health Sciences conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
2006-05-29
2015-12-09
Completed
85
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
2015-05-26
2017-03-31
Completed
221
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
2015-11-18
2020-12-01
Completed
113
A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
2016-11-09
2019-10-07
Completed
36
A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors
2016-09-27
2022-05-12
Completed
152
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A
2017-01-30
2022-06-29
Completed
48
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
2017-09-05
2020-11-19
Completed
195
A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma
2019-02-08
2023-11-30
Active, not recruiting
160
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Erciyes University Faculty of Health Sciences
According to Clinical.Site data, the most researched conditions in "Erciyes University Faculty of Health Sciences" are
"Appetitive Behavior" (1 trials), "HLA Antigens" (1 trials), "Healthy" (1 trials), "Insulin-Dependent Diabetes Mellitus 1" (1 trials) and "Liver Transplant; Complications" (1 trials). Many other conditions were trialed in "Erciyes University Faculty of Health Sciences" in a lesser frequency.
Clinical Trials Intervention Types at Erciyes University Faculty of Health Sciences
Most popular intervention types in "Erciyes University Faculty of Health Sciences" are "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Blueberry Cake" (1 trials), "Glucose Solution First Repeat" (1 trials), "Glucose Solution Second Repeat" (1 trials), "HGI-Kefir Breakfast" (1 trials) and "HLA antigen results" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Erciyes University Faculty of Health Sciences
The vast majority of trials in "Erciyes University Faculty of Health Sciences" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Erciyes University Faculty of Health Sciences
Currently, there are NaN active trials in "Erciyes University Faculty of Health Sciences".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Erciyes University Faculty of Health Sciences,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Erciyes University Faculty of Health Sciences, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".